GeneDx Holdings Corp. (WGS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-360.2%

-$166.78

vs $64.09 price

Levered DCF

-$190.15

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

1.28

Distress zone

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-178.16×	-39.62×	-0.38×	-0.16×	-1.96×	-10.99×	-75.92×
P/B	11.35×	8.43×	0.29×	0.35×	1.24×	467.16×	0×
P/S	8.18×	6.77×	0.33×	0.38×	2.27×	11.43×	9.28×
EV / EBITDA	534.93×	-75.89×	-0.64×	-0.07×	-0.52×	-8.74×	0×
Gross margin	69.7%	63.6%	44.4%	-11.4%	-7.8%	2.2%	42.2%
Operating margin	-2.8%	-7.6%	-89.2%	-284.5%	-210.3%	-134.9%	-15.5%
Net margin	-4.9%	-17.1%	-86.8%	-233.9%	-115.6%	-134.6%	-15.1%
Current ratio	2.46×	3.61×	3.1×	1.47×	4.77×	2.37×	0×
Debt / equity	0.49×	0.47×	0.53×	0.3×	0.08×	9.86×	0×
Interest coverage	-4.65×	-7.66×	0×	-208.19×	-157.37×	-97.81×	-38.84×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-6.8%	-21.3%	-77.1%	-216.4%	-63.2%	-5500.0%	0.0%
Return on invested capital	-2.5%	-6.3%	-49.3%	-148.8%	-97.8%	-133.2%	0.0%
Return on assets	-3.7%	-12.5%	-42.0%	-100.7%	-44.3%	-95.9%	0.0%
Free cash flow yield	0.4%	-1.6%	-278.0%	-374.0%	-43.8%	-6.1%	-1.9%
Earnings yield	-0.6%	-2.5%	-262.9%	-615.7%	-50.9%	-11.8%	-1.6%
Enterprise value	$3.5B	$2.1B	$86.9M	$28.9M	$114.3M	$2B	$0
Net debt / EBITDA	7.09×	-1.12×	-0.15×	0.15×	1.67×	0.29×	0×
Cash conversion cycle (days)	96	54	54	22	28	62	0